Annual report
6951.TEDINET S100TSO8
Period2023-04-01 → 2024-03-31
Filed2024-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥174.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥162.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥138.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥110.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥117.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥27.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥24.2bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥30.0bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥23.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥16.3bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.5bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥29.5bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥23.7bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥21.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.3bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.7bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.4bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥21.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥17.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥230.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥199.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥189.6bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥146.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥136.8bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥104.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥97.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥125.5bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥101.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥85.9bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥51.0bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥45.1bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥31.5bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥34.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥29.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥42.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥14.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥15.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥22.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥18.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥648m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥798m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥5.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥424.92 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥349.34 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥246.78 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.51 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.94 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,457.01 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,995.55 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,684.08 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,055.5 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥933.07 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 54.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 19.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.0% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.9% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,435 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 3,351 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 3,291 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 3,198 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 3,165 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥146.1bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥135.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥117.7bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥93.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥102.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥25.5bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥20.9bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥29.4bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥22.9bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥14.4bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.5bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.2bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥28.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥22.3bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥21.2bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥17.5bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥12.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥197.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥169.3bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥159.8bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥121.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥113.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥83.8bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥75.6bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥113.5bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥93.7bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥79.0bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥46.0bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥41.9bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥15.2bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥17.6bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥414.5 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥343.37 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.8 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.16 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.13 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥102 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥66 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,220.9 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,836 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,548.9 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥952.79 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥867.13 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 57.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.0% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.0% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.4% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.3% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 51,532,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,532,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,532,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 48,857,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 48,857,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,277 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 2,259 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 2,092 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 1,950 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 1,920 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥379m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥385m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥45.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥6.0bn |
| Industrial Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥1.9bn |
| Industrial Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥1.0bn |
| Industrial Equipmentreportable segment | employees | at 2024-03-31 | 567 pure |
| Industrial Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥39.0bn |
| Industrial Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥39.0bn |
| Industrial Equipmentreportable segment | segment assets | at 2024-03-31 | ¥59.3bn |
| Industrial Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥16.2bn |
| Medical Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥247m |
| Medical Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥359m |
| Medical Equipmentreportable segment | employees | at 2024-03-31 | 291 pure |
| Medical Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥15.3bn |
| Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥15.3bn |
| Medical Equipmentreportable segment | segment assets | at 2024-03-31 | ¥13.7bn |
| Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥475m |
| Scientific And Measurement Instrumentsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥3.0bn |
| Scientific And Measurement Instrumentsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥2.9bn |
| Scientific And Measurement Instrumentsreportable segment | employees | at 2024-03-31 | 2240 pure |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥120.0bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥120.0bn |
| Scientific And Measurement Instrumentsreportable segment | segment assets | at 2024-03-31 | ¥111.5bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥16.8bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥5.2bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥4.3bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥174.3bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥174.3bn |
| —segment total | segment assets | at 2024-03-31 | ¥184.5bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥33.5bn |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥449m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥381m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥45.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥5.4bn |
| Industrial Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥523m |
| Industrial Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Industrial Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥49.5bn |
| Industrial Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥49.5bn |
| Industrial Equipmentreportable segment | segment assets | at 2023-03-31 | ¥44.0bn |
| Industrial Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥23.3bn |
| Medical Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥158m |
| Medical Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥402m |
| Medical Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥18.4bn |
| Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥18.4bn |
| Medical Equipmentreportable segment | segment assets | at 2023-03-31 | ¥15.5bn |
| Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥530m |
| Scientific And Measurement Instrumentsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥2.5bn |
| Scientific And Measurement Instrumentsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2.8bn |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥94.8bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥94.8bn |
| Scientific And Measurement Instrumentsreportable segment | segment assets | at 2023-03-31 | ¥94.6bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥5.8bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥3.2bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥4.3bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥162.7bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥162.7bn |
| —segment total | segment assets | at 2023-03-31 | ¥154.1bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥29.6bn |
| Industrial Equipmentreportable segment | employees | at 2024-03-31 | 396 pure |
| Medical Equipmentreportable segment | employees | at 2024-03-31 | 272 pure |
| Scientific And Measurement Instrumentsreportable segment | employees | at 2024-03-31 | 1443 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,841
| Item | Context | Value | Unit |
|---|---|---|---|
| Loss gain on sales of investment securities ope cf | Prior1YearDuration | -825000000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYearDuration | -7000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YearDuration | 7000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYearDuration | 124000000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1YearDuration | -188000000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | CurrentYearDuration | -24000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YearDuration | -223000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYearDuration | -88000000 | JPY |
| Subsidy income ope cf | Prior1YearDuration | － | JPY |
| Subsidy income ope cf | CurrentYearDuration | -1332000000 | JPY |
| Impairment loss ope cf | Prior1YearDuration | 520000000 | JPY |
| Impairment loss ope cf | CurrentYearDuration | 603000000 | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -281000000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -397000000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 73000000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 88000000 | JPY |
| Loss on sales of notes and accounts receivable trade ope cf | Prior1YearDuration | 6000000 | JPY |
| Loss on sales of notes and accounts receivable trade ope cf | CurrentYearDuration | 1000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | -8442000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | -4169000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | -9522000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | -7559000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | 4857000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | -3971000000 | JPY |
| Decrease increase in consumption taxes receivable payable ope cf | Prior1YearDuration | -1347000000 | JPY |
| Decrease increase in consumption taxes receivable payable ope cf | CurrentYearDuration | 1233000000 | JPY |
| Increase decrease in contract liabilities ope cf | Prior1YearDuration | -4878000000 | JPY |
| Increase decrease in contract liabilities ope cf | CurrentYearDuration | 2997000000 | JPY |
| Other net ope cf | Prior1YearDuration | 571000000 | JPY |
| Other net ope cf | CurrentYearDuration | 300000000 | JPY |
| Subtotal ope cf | Prior1YearDuration | 9322000000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 22109000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 248000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 428000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -73000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -71000000 | JPY |
| Loss on sales of notes and accounts receivable trade paid ope cf | Prior1YearDuration | -6000000 | JPY |
| Loss on sales of notes and accounts receivable trade paid ope cf | CurrentYearDuration | -1000000 | JPY |
| Income taxes paid refund ope cf | Prior1YearDuration | -6139000000 | JPY |
| Income taxes paid refund ope cf | CurrentYearDuration | -7183000000 | JPY |
| Proceeds from subsidy ope cf | Prior1YearDuration | － | JPY |
| Proceeds from subsidy ope cf | CurrentYearDuration | 20000000 | JPY |
| Net cash provided by used in operating activities | Prior1YearDuration | 3351000000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration | 15301000000 | JPY |
| Decrease increase in time deposits inv cf | Prior1YearDuration | -272000000 | JPY |
| Decrease increase in time deposits inv cf | CurrentYearDuration | 744000000 | JPY |
| Purchase of investment securities inv cf | Prior1YearDuration | -134000000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | -15736000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YearDuration | 863000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYearDuration | 12000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |